Recent Featured Videos and Articles | Eastern “Orthodoxy” Refuted | How To Avoid Sin | The Antichrist Identified! | What Fake Christians Get Wrong About Ephesians | Why So Many Can't Believe | “Magicians” Prove A Spiritual World Exists | Amazing Evidence For God | News Links |
Vatican II “Catholic” Church Exposed | Steps To Convert | Outside The Church There Is No Salvation | E-Exchanges | The Holy Rosary | Padre Pio | Traditional Catholic Issues And Groups | Help Save Souls: Donate | ![]() |
"Javier Milei Spends Nearly $1 Billion On Trans Hormones For Argentine Kids"
"The government of Argentine President Javier Milei is spending a whopping $827 million Argentine Pesos on transgender sex change hormones, including puberty blockers that will be provided to children deemed trans. The massive purchase of body mutilation drugs comes after Milei, a member of Argentina’s Libertarian Party, was both hailed and demonized as a 'right-wing' icon and government spending slasher by media and political figures all over the world – especially in the United States.
According to the Argentine news publication El Disenso, 'the Milei government will spend 827 million on inputs for the homogenization of children, adolescents and trans adults.'
In other words, Milei is spending at least $827 million Argentine Pesos (equivalent to $972,442 USD) to facilitate the mutilation and complete bodily destruction of Argentine children, and other citizens.
As El Diseno reported:
The current government has just published the approval of a purchase of $ 827,255,100 in body modification hormones for the gender and diversity program that provides free inhibition drugs and pubertal induction for children, adolescents and trans adults.
With the signature of Nicolás Posse and Mario Antonio Russo, the government today enabled the purchase of 105,000 containers of inputs for hormonalization requested by the Directorate of Gender and Diversity within the framework of Law 26,743."
Sign up for our free e-mail list to see future vaticancatholic.com videos and articles.
Recent Content
^